Skip to main content
Parthiv Mehta, MD, Radiation Oncology, Glenview, IL

ParthivSMehtaMD(He/Him)

Radiation Oncology Glenview, IL

Medical Director

Dr. Mehta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mehta's full profile

Already have an account?

Summary

  • Dr. Parthiv Mehta is a radiation oncologist in Glenview, IL and is affiliated with Uropartners. He received his medical degree from University of Illinois College of Medicine and has been in practice 16 years. He also speaks multiple languages, including Spanish and Gujarati. He is experienced in prostate cancer.

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterResidency, Radiation Oncology, 2002 - 2006
  • Rush University Medical Center
    Rush University Medical CenterInternship, Transitional Year, 2001 - 2002
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2001

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2001 - 2026
  • NC State Medical License
    NC State Medical License 2012 - 2014
  • NY State Medical License
    NY State Medical License 2006 - 2008
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • Weight Gain in Advanced Non-Small Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoraiotherapy Is Associated With Superior Survival  
    Gielda, Mehta, Khan, Marsh, Zusag, Warren, Fidler, Abrams, Bonomi, Liptay, and Faber, Int J Rad Onc Bio Physics
  • Function and Organ Perservation in Adult Cancers of the Head and Neck  
    Mehta PS and Harrison LB, Expert Review of Anticancer Therapy
  • Weight Gain in Advanced Non-Small Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival  
    Gielda, Mehta, Khan, Marsh, Zusag, Warren, Fidler, Abrams, Bonomi, Liptay, and Faber, International Journal of Radiation Oncology Biology Physics
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Initial Clinical Results with Mammosite Breast Brachytherapy Applicator in Women with Early-Stage Breast Cancer
    Choo JJ, Mehta PS, Nguyen CN, Hasabou N, Schochet E, Gittleman MA, Henson R, Snider HC, Dowlatshahi K, ASTRO
  • A dosimetric analysis comparing an electron tumor bed boost with a tumor bed boost utilizing the Mammosite breat brachytherapy aplicator
    Kirk M, Dickler AD, Mehta PS, Khan AJ, Chu J, Griem KL, Nguyen C, ASTRO
  • A dosimetric comparison of 3D conformal, IMRT, and Mammosite partial breast radiation
    Dickler A, Kirk M, Khan AJ, Mehta PS, Chu J, Griem KL, Nguyen C, ASTRO
  • Join now to see all

Lectures

  • Split Course Radiotherapy with concurrent, cytotoxic chemotherapy for stage III non-small cell lung cancer: decreased acute and late toxicity without comromised efficacy 
    RSNA

Professional Memberships

Other Languages

  • Spanish, Gujarati, Hindi, Urdu